Our finding that the effect of MTA on macrophage functionality is mediated by the adenosine A2B receptor and is amenable to pharmacological intervention adds a new line of evidence to support the rationale of targeting A2B receptor signaling in MTAP-deficient GBM. Here, ADORA2B is linked to glioblastoma.